![]() | ![]() |
Samsung Biologics Announces Manufacturing Deal with European Pharmaceutical Company
Samsung Biologics is set to add antibody-drug conjugate (ADC) services to its portfolio, with a dedicated facility to be completed by the end of this year.
Samsung Biologics | 20/11/2024 | By Aishwarya
Samsung Biologics Secures ISO Certifications for its Business Excellence
The certifications were presented by the British Standards Institution (BSI) during a ceremony held at Samsung Biologics' headquarters.
Samsung Biologics | 11/11/2024 | By Aishwarya | 119
Samsung Biologics Inks Manufacturing Deal with Asian Pharmaceutical Company
With the latest agreement, the company's accumulated contract for 2024 surpasses USD 3.3 billion.
Samsung Biologics | 22/10/2024 | By Aishwarya | 122
Samsung Biologics Develops High-Concentration Formulation Platform for Drug Development
S-HiCon can proactively identify unintended pH changes, enhance formulation stability, and reduce viscosity to ensure efficacy and maximize drug delivery.
Samsung Biologics | 15/10/2024 | By Aishwarya | 144
Samsung Biologics Introduces Development Platforms for Enhanced Therapeutic Efficacy
Samsung Biologics has unveiled a series of proprietary development platforms as part of continued efforts to ensure high-quality development and provide client-tailored services.<br />
Samsung Biologics | 26/09/2024 | By Aishwarya | 172
Samsung Biologics Joins Pharmaceutical Supply Chain Initiative as Supplier Partner
Samsung Biologics, a global contract development and manufacturing organization (CDMO), has joined the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner.
Samsung Biologics | 08/08/2024 | By Aishwarya | 162
Samsung Biologics set to begin construction of new $1.5B plant
The investment will add 180,000 litres of capacity to the complex in Incheon, bringing total capacity to 784,000 litres, the most at a single site in the industry
Samsung Biologics | 03/05/2023 | By Sudeep Soparkar | 362
Samsung Biologics eyes strategic expansion in Korea
The company plans to begin construction in the first half of 2023 and commence operations in 2025
<br />
Samsung Biologics | 21/03/2023 | By Sudeep Soparkar | 418
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy